Abstract
Toxoplasmosis is a rare but important infection in pregnant women which can potentially cause serious fetal adverse effects. Methods of screening, diagnosing and treating toxoplasmosis in pregnancy have been evaluated for over four decades now but still, there is a lack of robust evidence in these areas to guide care plans. Yet with the advent of newer techniques in imaging and laboratory diagnosis, reasonable protocols can be formulated to optimally mange cases with toxoplasmosis in pregnancy. It is becoming increasingly evident that antenatal treatment definitely helps in reducing fetal and hence neonatal morbidity from this infection. Timely identification and adequate therapy to prevent vertical transmission or even treat infected fetuses seem to be a practical approach. Most importantly, health education and public awareness will help reduce the infection rates in pregnant women.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Sensini A. Toxoplasma gondii infection in pregnancy: opportunities and pitfalls of serological diagnosis. Clin Microbiol Infect. 2006;12(6):504–12.
Cook AJ, Gilbert RE, Buffolano W, et al. Sources of § infection in pregnant women: European multicentre case-control study. European research network on congenital toxoplasmosis. BMJ. 2000;321:142.
Remington JSMR, Wilson CB, Desmonts G. Toxoplasmosis. In: Remington JSKJ, editor. Infectious diseases of the fetus and newborn infant. 7th ed. Philadelphia: Saunders/Elsevier; 2011.
Petersen E, Edvinsson B, Lundgren B, Benfield T, Evengard B. Diagnosis of pulmonary infection with Toxoplasma gondii in immunocompromised HIV-positive patients by real-time PCR. Eur J Clin Microbiol Infect Dis. 2006;25:401–4.
Burnett AJ, Shortt SG, Isaac-Renton J, King A, Werker D, Bowie WR. Multiple cases of acquired toxoplasmosis retinitis presenting in an outbreak. Ophthalmology. 1998;105:1032–103.
Gilbert R, Gras L. European Multicentre study on congenital toxoplasmosis. Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii. BJOG. 2003;110:112.
Gilbert RE. Congenital toxoplasmosis: scientific background, clinical management and control. In: Petersen E, Amboise-Thomas P, editors. Epidemiology of infection in pregnant women. 1st ed. Paris: Springer; 2000.
Singh S, Munawwar A, Rao S, et al. Serologic prevalence of Toxoplasma gondii in Indian women of child bearing age and effects of social and environmental factors. PLoS Negl Trop Dis. 2014;8:e2737.
Gras L, Gilbert RE, Wallon M, Peyron F, Cortina-Borja M. Duration of the IgM response in women acquiring Toxoplasma gondii during pregnancy: implications for clinical practice and cross-sectional incidence studies. Epidemiol Infect. 2004;132:541–8.
Bessieres MH, Roques C, Berrebi A, Barre V, Cazaux M, Seguela JP. IgA antibody response during acquired and congenital toxoplasmosis. J Clin Pathol. 1992;45:605–8.
Villarda O, Cimon B, L’Ollivier C, et al. Serological diagnosis of Toxoplasma gondii infection: recommendations from the French National Reference Center for Toxoplasmosis. Diagn Microbiol Infect Dis. 2016;84(1):22–33.
Liesenfeld O, Montoya JG, Kinney S, Press C, Remington JS. Effect of testing for IgG avidity in the diagnosis of Toxoplasma gondii infection in pregnant women: experience in a US reference laboratory. J Infect Dis. 2001;183:1248–53.
Maldonado YA, Read JS. Diagnosis, treatment, and prevention of congenital toxoplasmosis in the United States. Pediatrics. 2017;139(2):e20163860. https://doi.org/10.1542/peds.2016-3860
Paquet C, Yudin MH. Society of obstetricians and gynaecologists of Canada. Toxoplasmosis in pregnancy: prevention, screening, and treatment. J Obstet Gynaecol Can. 2013;35:78.
Cornu C, Bissery A, Malbos C, et al. Factors affecting the adherence to an antenatal screening programme: an experience with toxoplasmosis screening in France. Eurosurveillance. 2009;14:21.
Hohlfeld P, MacAleese J, Capella-Pavlovski M, et al. Fetal toxoplasmosis: ultrasonographic signs. Ultrasound Obstet Gynecol. 1991;1:241.
Malinger G, Werner H, Rodriguez Leonel JC, et al. Prenatal brain imaging in congenital toxoplasmosis. Prenat Diagn. 2011;31:881.
de Oliveira Azevedo CT, do Brasil PE, Guida L, Lopes Moreira ME. Performance of polymerase chain reaction analysis of the amniotic fluid of pregnant women for diagnosis of congenital toxoplasmosis: a systematic review and meta-analysis. PLoS ONE. 2016;11:e0149938.
Findal G, Helbig A, Haugen G, Jenum PA, Stray-Pedersen B. Management of suspected primary Toxoplasma gondii infection in pregnant women in Norway: twenty years of experience of amniocentesis in a low-prevalence population. BMC Pregnancy Childbirth. 2017;17(1):127.
Lebech M, Joynson DH, Seitz HM, Thulliez P, Gilbert RE, Dutton GN, Ovlisen B, Petersen E. Classification system and case definitions of Toxoplasma gondii infection in immunocompetent pregnant women and their congenitally infected offspring. European research network on congenital toxoplasmosis. Eur J Clin Microbiol Infect Dis. 1996;15(10):799–805.
SYROCOT (Systematic Review on Congenital Toxoplasmosis) study group, Thiébaut R, Leproust S, Chêne G, Gilbert R. Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients’ data. Lancet. 2007;369(9556):115–22.
Mandelbrot L, Kieffer F, Sitta R, et al. Prenatal therapy with pyrimethamine + sulfadiazine vs spiramycin to reduce placental transmission of toxoplasmosis: a multicenter, randomized trial. Am J Obstet Gynecol. 2018;219(386):e1.
Cortina-Borja M, Tan HK, Wallon M, et al. Prenatal treatment for serious neurological sequelae of congenital toxoplasmosis: an observational prospective cohort study. PLoS Med. 2010;7:e1000351. https://doi.org/10.1371/journal.pmed.1000351.
Kaye A. Toxoplasmosis: diagnosis, treatment, and prevention in congenitally exposed infants. J Pediatr Health Care. 2011;25(06):355–64.
Di Mario S, Basevi V, Gagliotti C, et al. Prenatal education for congenital toxoplasmosis. Cochrane Database Syst Rev. 2013;CD006171.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ratha, C. Toxoplasmosis in Pregnancy. J. Fetal Med. 7, 31–35 (2020). https://doi.org/10.1007/s40556-019-00227-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40556-019-00227-5